Haemonetics (NYSE:HAE) reported its Q4 earnings results on Tuesday, May 10, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Haemonetics beat estimated earnings by 8.33%, reporting an EPS of $0.65 versus an estimate of $0.6.
Revenue was up $39.97 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 4.33% increase in the share price the next day.
Here's a look at Haemonetics's past performance:
| Quarter | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.73 | 0.61 | 0.46 | 0.67 |
| EPS Actual | 0.84 | 0.60 | 0.50 | 0.46 |
| Revenue Estimate | 266.74M | 241.40M | 219.35M | 222.98M |
| Revenue Actual | 259.77M | 239.90M | 228.53M | 225.03M |
To track all earnings releases for Haemonetics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
